Displaying 2861 - 2880 of 9391
FTC Releases Reports on Cigarette and Smokeless Tobacco Sales and Marketing Expenditures for 2017
Statement of the Federal Trade Commission Concerning Cigarette and Smokeless Tobacco 6(b) Orders
FTC Brings First Case Challenging Fake Paid Reviews on an Independent Retail Website
FTC and CFPB Reauthorize Memorandum of Understanding
FTC Staff Provides Annual Letter to CFPB with ECOA Activities
FTC Halts Fake Job Opportunity and Resume Repair Operation
FTC Returns $1.95 Million to Consumers Who Bought NutriMost Ultimate Fat Loss System in the Pittsburgh Area
FTC Approves Final Order with SoFi
Social Finance, Inc. and Sofi Lending Corp., In the Matter of
In October 2018, the FTC announced that online student loan refinancer SoFi Lending Corp. (SoFi) agreed to stop misrepresenting how much money student loan borrowers have saved, or will save, by refinancing their loans with the company. The Commission approved the final consent in February 2019. In its administrative complaint, announced concurrently with the proposed settlement, the FTC alleged that since April 2016 SoFi made prominent false statements about loan refinancing savings in television, print, and Internet advertisements.
NutriMost LLC
The FTC is mailing 3,483 checks totaling more than $1.95 million to consumers who bought the NutriMost Ultimate Fat Loss System between October 1, 2012 and August 9, 2016, in the Pittsburgh, Pennsylvania area. Each consumer will receive a refund of $560.54.
FTC Announces Agenda for the Tenth Session of its Hearings on Competition and Consumer Protection in the 21st Century
FTC Approves Final Consent Order against Company and Owner Who Allegedly Made Unsupported Health Claims for Intravenously Injected Therapy Products
A&O Enterprises, doing business as iV Bars, and Aaron K. Roberts, In the Matter of
Following a public comment period, the FTC has approved a final order settling charges against a Texas-based marketer and seller of intravenously injected therapy products (IV Cocktails) who allegedly made a range of deceptive and unsupported health claims about their ability to treat serious diseases such as cancer, multiple sclerosis, and congestive heart failure.
Defendants in “Cash From Home” Business Opportunity Scheme Settle with FTC
Displaying 2861 - 2880 of 9391